XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Revenues - Revenues Disaggregated by Concentration Risks (Details) - Customer Concentration Risk
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 29, 2023
Sep. 30, 2022
Sep. 29, 2023
Sep. 30, 2022
Dec. 30, 2022
Affiliates of McKesson Corporation | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 18.00% 18.00% 17.00% 18.00%  
Affiliates of McKesson Corporation | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     22.00%   22.00%
Affiliates of AmerisourceBergen Corporation | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 18.00% 18.00% 17.00% 16.00%  
Affiliates of AmerisourceBergen Corporation | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     19.00%   18.00%
Affiliates of CVS Health Corporation | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 17.00% 19.00% 17.00% 17.00%  
Affiliates of CVS Health Corporation | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     14.00%   18.00%
Accredo Health, Incorporated | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 12.00% 11.00% 12.00% 10.00%  
Affiliates of Optum Specialty Pharmacy | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 10.00% 9.00% 10.00% 9.00%  
Ipsen Pharma SAS | Revenue          
Concentration Risk [Line Items]          
Percent of total revenues 8.00% 8.00% 8.00% 11.00%  
Ipsen Pharma SAS | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     18.00%   20.00%
Cardinal Health, Inc. | Accounts Receivable          
Concentration Risk [Line Items]          
Percent of total revenues     9.00%   11.00%